[Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
Matsumoto
S
S
Dept. of Orthopedic Surgery, Cancer Institute Hospital.
Kawaguchi
N
N
Manabe
J
J
Kuroda
H
H
Shimoji
T
T
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D003556:Cystitis / Q000139:chemically induced* / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D015080:Mesna / Q000627:therapeutic use*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000188:drug therapy
D015080:Mesna; D002945:Cisplatin; D007069:Ifosfamide; D008727:Methotrexate